Radiocontrast-induced nephropathy and percutaneous coronary intervention: a review of preventive measures

Bibliography

• SCHREINER GE: Nephrotoxicity and diagnostic agents. (1966) 196:127–129.
   Google Scholar
• PENDERGRASS EP, CHAMBERLIN GW, GODFREY EW, BURDICK ED: A survey of deaths and unfavorable sequelae following administration of contrast media.Amer. J. Roentgen (1942) 48:741–762.
   Google Scholar
• MILLER GM, WYLIE EJ, HINMAN F Jr: Renal complications from aortography. Surgery (1954) 35:885–896.
   PubMed Web of Science ®Google Scholar
• IDBOHRN H: Tolerance to contrast media in renal angiography. Acta Radial. (1956) 45:141.
   PubMed Web of Science ®Google Scholar
• MCAFEE JG: A survey of complications ofabdominal aortography. Radiology (1957) 68:825–838.
   PubMed Web of Science ®Google Scholar
• BARTELS ED et al: Acute anuria followingintravenous pyelography in a patient withmyelomatosis. Acta Med. Scand. (1954) 150:297–302.
   PubMedGoogle Scholar
• MYHRE JR, BROD WALL EK, KNUTSEN SB: Acute renal failure following intravenous pyelography in cases of myelomatosis. Acta Med. Scam/. (1956) 156:263–266.
   PubMedGoogle Scholar
• RICH MW CRECELIUS CA: Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older.A prospective study. Arch. Intern. Med. (1990) 150:1237–1242.
   Google Scholar
• LASSER EC, LANG JH, ZAWADZKI ZA: Contrast media: myeloma protein precipitates in urography. JAMA (1966) 198:273–275.
   Web of Science ®Google Scholar
• THATTE L, VAAMONDE CA: Drug-induced nephrotoxicity: the crucial role of risk factors. Postgrad. Med. (1996) 100:83–91.
   PubMed Web of Science ®Google Scholar
• MCCULLOUGH PA, WOLYN R, ROCHER LL, LEVIN RN,O'NEILL WW: Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am. J. Med. (1997) 103:368–375.
   PubMed Web of Science ®Google Scholar
• ••One of the best studies regarding CIN incoronary artery disease patients undergoing coronary intervention by one of the leading experts in the field.
   Google Scholar
• RIHAL CS, TEXTOR SC, GRILL DE etal.: Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation (2002) 105:2259–2264.
   Google Scholar
• GRUBERG L, MINTZ GS, MEHRAN R et al.: The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existing chronic renal insufficiency. J. Am. Coll. Cardiol (2000) 36:1542–1548.
   PubMed Web of Science ®Google Scholar
• •This retrospective study showed the dismal outcome of patients with chronicExpert Op/n. Pharmacother. (2003) 4(5)649 insufficiency who undergo percutaneous coronary intervention.
   Google Scholar
• NASH K, HAFEEZ A, HOU S: Hospital-acquired renal insufficiency. Am. j Kidney Dis. (2002) 39:930–936.
   PubMed Web of Science ®Google Scholar
• HEYMAN SN, REICHMAN J, BREZIS M: Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest. Radial. (1999) 34:685–691.
   PubMed Web of Science ®Google Scholar
• AGRAWAL M, STOUFFER GA: Cardiology grand rounds UNC: contrast induced nephropathy after angiography. Am. J. Med. Sci. (2002) 323:252–258.
   PubMed Web of Science ®Google Scholar
• HARDIEK K, KATHOLI RE,VICKRAM R, DEITRICK C: Proximal tubule cell response to radiographic contrast media. Am. J. Physial Rena] Physial (2001) 280:F61–F70.
   Web of Science ®Google Scholar
• KEELEY EC, GRINES CL: Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1000 cases. JACC(1998) 32: 1861-1865.
   Google Scholar
• PALLONE TL, ZHANG Z, RHINEHART K: Physiology of renal medullary microcirculation. Am. I Physial Rena] Physial (2003) 284:F253–F266.
   Web of Science ®Google Scholar
• HEYMAN SN, BREZIS M, REUBINOFF CA etal.: Acute renal failure with selective medullary injury in the rat. Clin. Invest. (1988) 82:401–412.
   Google Scholar
• HEYMAN SN, BREZIS M, EPSTEIN FH et al: Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int. (1991) 40:632–642.
   PubMed Web of Science ®Google Scholar
• KATZBERG RW, MORRIS TW, LASSER EC etal.: Acute systemic and renal hemodynamic effects of meglumine/ sodium diatrizoate 76% and iopamidol in euvolemic and dehydrated dogs. Invest. Radial. (1986) 21:793–797.
   Google Scholar
• LEEMING BWA, SPOKES K, SILVA P: Effect of meglumine iothalamate on renal hemodynamics and function in the diabetic rat. Invest. Radial. (1985) 20:971–977.
   PubMed Web of Science ®Google Scholar
• WORKMAN RJ, SHAFF MI,JACKSON RV et al: Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest. Radial. (1983) 18:160–166.
   PubMed Web of Science ®Google Scholar
• LISS P: Effects of contrast media on renal microcirculation and oxygen tension. An experimental study in the rat. Acta Radial. Suppl. (1997) 409:1–29.
   PubMedGoogle Scholar
• LANCELOT E, IDEE JM,COUTERIER V, VAZIN V, COROT C: Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: a potential cause of nephrotoxicity.Appl. Taxical (1999) 19:341–346.
   PubMed Web of Science ®Google Scholar
• PORTER GA: Contrast-associated nephropathy: presentation, pathophysiology, and management. Miner Electrolyte Metab. (1994) 20:232–243.
   PubMedGoogle Scholar
• BERG KJ: Nephrotoxicity related to contrast media. Scalar/. I Ural. Nephrol (2000) 34:317–322.
   PubMed Web of Science ®Google Scholar
• MURPHY ME, TUBLIN ME, LI S: Influence of contrast media on the response of rat renal arteries to endothelin and nitric oxide: influence of contrast media. Invest. Radial. (1998) 33:356–365.
   PubMed Web of Science ®Google Scholar
• TAYLOR AJ, HOTCHKISS D,MORSE RW et al: PREPARED: preparation for angiography in renal dysfunction. A randomized trial of inpatient versus outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest (1998) 114:1570–1574.
   Google Scholar
• BARRETT BJ, PARFREY PS: Preventionof nephrotoxicity induced by radiocontrast agents. N Engl. j Med. (1994) 331:1449–1450.
   PubMed Web of Science ®Google Scholar
• MUELLER C, BUERKLE G, BUETTNER HJ etal.: Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch. Intern. Med. (2002) 162:329–336.
   Google Scholar
• ••A simple idea carried out in a very largenumber of patients shows significant results.
   Google Scholar
• TRIVEDI HS, MOORE H, NASR S et al:A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron (2003) 93:C29–C34.
   Web of Science ®Google Scholar
• SOLOMON R, WERNER C, MANN D etal.: Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N. Engl. J. Med. (1994) 331:1416–1420.
   Google Scholar
• WEINSTEIN JM, HEYMAN S, BREZIS M: Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron (1992) 62:413–415.
   PubMed Web of Science ®Google Scholar
• STEVENS MA, MCCULLOUGH PA, TOBIN KJ etal.: A prospective randomizedtrial of prevention measures in patients at high risk for contrast nephropathy: results of the PRINCE study. J Am. Coll Cardial (1999) 33:403–411.
   Google Scholar
• •A key study regarding contrast selection for coronary angiography.
   Google Scholar
• MOON SS, BACK SE, KURKUS J et al: Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function. Nephron (1995) 70:430–437.
   PubMed Web of Science ®Google Scholar
• LEHNERT T, KELLER E, GONDOLF K et al.: Effect of hemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial. Transplant. (1998) 13:358–362.
   PubMed Web of Science ®Google Scholar
• STERNER G, FRENNBY B, KURKUS J et al.: Does post-angiographic hemodialysis reduce the risk of contrast medium nephropathy? Scand. j Ural. Nephrol (2000) 34:323–326.
   PubMed Web of Science ®Google Scholar
• VOGT B, FERRARI P, SCHONHOLZER C etal.:Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am. J. Med. (2001) 111:692–698.
   Google Scholar
• HUBER W, JESCHKE B, KREYMANN B et al.: Haemodialysis for the prevention of contrast-induced nephropathy.Invest. Radial. (2002) 37(9):471–481.
   Google Scholar
• LEVEY AS, BOSCH JP, LEWIS JB etal.: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann. Intern. Med. (1999)130:461–470.
   Google Scholar
• CIGARROA RG, LANGE RA, WILLIAMS RH, HILLIS LD: Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am. j Med. (1989) 86:649–652.
   PubMed Web of Science ®Google Scholar
• FREEMAN RV, O'DONELL M, SHARE D et al: Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am. j Cardial (2002) 90:1068–1073.
   Google Scholar
• BARRETT BJ, CARLISLE EJ: Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology (1993) 188:171–178.
   PubMed Web of Science ®Google Scholar
• ESPLUGAS E, CEQUIER A, GOMEZ-HOSPITAL JA: Comparative tolerability of contrast media used for coronary interventions. Drug Safety (2002) 25 (15):1079–98.
   PubMed Web of Science ®Google Scholar
• GRINES CL, SCHREIBER TL, SAVAS Vet al.: A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty.film. Coll. Cardiol (1996) 27:1381–1386.
   Google Scholar
• SCHRADER R, ESCH I, ENSSLEN R et al.: A randomized trial comparing the impact of a nonionic (iomeprol) versus an ionic (ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. J. Am. Coll. Cardiol (1999) 33:395–402.
   PubMed Web of Science ®Google Scholar
• DAVIDSON CJ, LASKEY WK,HERMILLER JB etal.: Randomized trial of contrast media utilization in high-risk PTCA, the COURT trial. Circulation (2000) 101:2172–2177.
   Google Scholar
• ASPELIN P, AUBRY P, FRANSSON SG et al.: Nephrotoxic effects in high-risk patients undergoing angiography. N Engl. J. Med. (2003) 348:491–499.
   PubMed Web of Science ®Google Scholar
• STERNER G, NYMAN U, VALDES T: Low risk of contrast-medium-induced nephropathy with modern angiographic technique. I IrM Med. (2001) 250: 429–434.
   Google Scholar
• SPINOSA DJ, KAUFMANN JA, HARTWELL GD: Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology (2002) 223:319–325.
   PubMed Web of Science ®Google Scholar
• RIEGER J, SITTER T, TOEPFER M: Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial. Transplant. (2002) 17:824–828.
   PubMed Web of Science ®Google Scholar
• KURNIK BR, ALLGREN RL,GENTER FC et al.: Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am. I Kidney Dis. (1998) 31:674–80.
   Google Scholar
• GUPTA RK, KAPOOR A TEWARI S et al.: Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomized study. Indian Heart J. (1999) 51:521–526.
   Google Scholar
• KOCH JA, PLUM J, GRABENSEE B et al.: Prostaglandin El: a new agent for the prevention of renal dysfunction in high-risk patients caused by radiocontrast media? Nephrol Dial. Transplant. (2000) 15:43–49.
   Web of Science ®Google Scholar
• SKETCH MH JR, SCHOLLMAYER WA, KOCH JA et al.: Prevention of contrast media-induced renal dysfunction with prostaglandin El: a randomized, double-blind, placebo-controlled study. Am. J. Ther. (2001) 8:155–162.
   PubMedGoogle Scholar
• POLLOCK DM, POLAKOWSKI JS, WEGNER CD et al.: Beneficial effect of ETA receptor blockade in a rat model of radiocontrast-induced nephropathy. Rem Fail (1997) 19:753–761.
   PubMed Web of Science ®Google Scholar
• WANG A, HOLCSLAW T,BASHORE TM et al: Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int. (2000) 57:1575–1580.
   Web of Science ®Google Scholar
• ARAKAWA K, SUZUKI H, NAITOH M et al: Role of adenosine in the renal responses to contrast medium. Kidney Int. (1996) 49:1199–1206.
   PubMed Web of Science ®Google Scholar
• KATHOLI RE, TAYLOR GJ,MCCANN WP et al: Nephrotoxicity from contrast media: attenuation with theophylline. Radiology (1995) 195:17–22.
   PubMed Web of Science ®Google Scholar
• ABIZAID AS, CLARK CE, MINTZ GS et al: Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am. J. Cardiol (1999) 83:260–263.
   PubMed Web of Science ®Google Scholar
• SHAMMAS NW, KAPALIS MJ,HARRIS M et al.: Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures.f Invasive. Cardiol (2001) 13:738–740.
   Google Scholar
• KAPOOR A, KUMAR S, GULATI S et al:The role of theophylline in contrast-induced nephropathy: a case-control study. Nephrol Dial. Transplant. (2002) 17:1936–1941.
   PubMed Web of Science ®Google Scholar
• HUBER W, JESCHKE B, PAGE M et al:Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk. Intensive Care Med. (2001) 27:1200–1209.
   PubMed Web of Science ®Google Scholar
• HUBER W, ILGMANN K, PAGE Metal.: Effect of theophylline on contrast material-induced nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study. Radiology (2002) 223:772–779.
   Google Scholar
• DUAN SB, LIU FY, LUO JA et al: Nephrotoxicity of high- and low-osmolar contrast media. The preventative role ofamlodipine in a rat model. Acta Radiol. (2000) 41:503–507.
   Google Scholar
• WANG Y-XJ, JIA Y-F, CHEN K-M et al.:Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers. Br f Radiol. (2001) 74:1103–1108.
   PubMed Web of Science ®Google Scholar
• CARRARO M, MANCINI W, ARTERO M etal.: Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. Nephrol. Dial. Transplant. (1996) 11:444–448.
   Google Scholar
• HUNTER DW, CHAMSUDDIN A BJARNASON H et al.: Preventing contrast-induced nephropathy with fenoldopam. Tech. Vasc. Interv. Radiol. (2001) 4:53–56.
   PubMedGoogle Scholar
• MADYOON H, CROUSHORE L, WEAVER D et al.: Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients. Catheter Cardiovasc. Intervent. (2001) 53:341–345.
   PubMed Web of Science ®Google Scholar
• WEISBERG LS, KURNIK PB, KURNIK BR: Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. (1994) 45:259–265.
   PubMed Web of Science ®Google Scholar
• CHAMSUDDIN AA, KOWALIK KJ, BJARNASON J et al.: Using a dopamine Type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy. Am. I Roentgen (2002) 179:591–596.
   PubMed Web of Science ®Google Scholar
• KINI A, MITRE C, KAMRAN M et al.: Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. Am. J. Cardiol (2002) 89:999–1002.
   PubMed Web of Science ®Google Scholar
• TUMLIN JA, WANG A, MURRAY PT etal.: Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am. Heart J. (2002) 143:894–903.
   Google Scholar
• CONESA EL, VALERO F, NADAL JC etal.: N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am. I Physiol Reg. Integrative Comp. Physiol (2001) 281:R730–R737.
   Web of Science ®Google Scholar
• HEYMAN SN, GOLDFARB M, SHINA A, KARMELI F, ROSEN S: N-acetylcysteine ameliorates renal microcirculation: studies in rats. Kidney Int. (2003) 63:634-641. 651Expert Op/n. Pharmacother. (2003) 4(5)
   Google Scholar
• HIZOH I, HALLER C: Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest. Radial. (2002) 37:428–434.
   PubMed Web of Science ®Google Scholar
• TEPEL M, VAN DER GIET M, SCHWARZFELD C et al.: Prevention of radiographic-contrast-agent-induced reductions in renal functions by acetylcysteine. N Eng1J. Med. (2000) 343:180–184.
   Google Scholar
• ••Key article on the use of acetylcysteine forthe prevention of CIN.
   Google Scholar
• DIAZ-SANDOVAL LJ, KOSOWSKY BD, LOSORDO DW: Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am. J. Cardiol. (2002) 89:356–358.
   PubMed Web of Science ®Google Scholar
• SHYU KG, CHENG JJ, KUAN P: Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J. Am. Coll. Cardiol (2002) 40:1383–1388.
   PubMed Web of Science ®Google Scholar
• DURHAM JD, CAPUTO C, DOKKO J etal.: A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney mt. (2002) 62:2202–2207.
   Google Scholar
• BRIGUORI C, MANGANELLI J, SCARPATO P et al: Acetylcysteine and contrast agent-associated nephrotoxicity. J. Am. Coll. Cardiol (2002) 40:298–303.
   PubMed Web of Science ®Google Scholar
• ••A very important article regarding the useof acetylcysteine for the prevention CIN.
   Google Scholar
• ALLAQABAND S, TUMULURI R, MALIK AM et al: Prospective randomized study of n-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardio vase. Interv. (2002) 57:279–283.
   PubMed Web of Science ®Google Scholar
• KAY J, CHOW WH, CHAN TM et al: Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA (2003) 289:553–558.
   PubMed Web of Science ®Google Scholar
• ••A very important article regarding the useof acetylcysteine for the prevention CIN. published in one of the most influential journals in medicine.
   Google Scholar
• STONE GW, TUMLIN JA,MADYOON H et al: Design and rationale of CONTRAST — a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy. Rev Cardiovasc. Med. (2001) 2\(Suppl. 1):531–536.
   Google Scholar